Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MannKind (NNFN) vs. Competitors

10 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:NNFNMannKindEUR 3.54EUR 1.16B-16.75-20.27%Strong BuyUnlock the DE:NNFN analyst price target with TipRanks PremiumDE:NNFNUnlock the DE:NNFN top-analyst price target with TipRanks Premium
LXRXLexicon Pharmaceuticals$1.78$779.16M-12.0121.92%Strong BuyUnlock the LXRX analyst price target with TipRanks PremiumDE:NNFN vs LXRXUnlock the LXRX top-analyst price target with TipRanks Premium
INVAInnoviva$18.30$1.31B7.31-16.70%Strong BuyUnlock the INVA analyst price target with TipRanks PremiumDE:NNFN vs INVAUnlock the INVA top-analyst price target with TipRanks Premium
SVRASavara$4.48$985.08M-7.306.67%Strong BuyUnlock the SVRA analyst price target with TipRanks PremiumDE:NNFN vs SVRAUnlock the SVRA top-analyst price target with TipRanks Premium
XERSXeris Pharmaceuticals$16.80$3.05B-415.34131.40%Strong BuyUnlock the XERS analyst price target with TipRanks PremiumDE:NNFN vs XERSUnlock the XERS top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:NNFNMannKind3.54-0.71-16.73%
LXRXLexicon Pharmaceuticals1.780.3121.09%
INVAInnoviva18.30-3.57-16.32%
SVRASavara4.480.317.43%
XERSXeris Pharmaceuticals16.809.72137.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts